AKT1 and lymphoma: In lymphoma cell lines, FWGP induced expression of cell cycle inhibitors—e.g., p53—resulting in cell cycle arrest, upregulated pro-apoptotic pathways (increased BAD and BAK expression, along with caspase 3/7 cleavage), and downregulated anti-apoptotic marker AKT [11,12].